2025. HYPERKALEMIA RISK COMPARISON IN PATIENTS ON VALSARTAN/SACUBITRIL: NORMAL RENAL PROFILE VERSUS ADVANCED CHRONIC KIDNEY DISEASE. The Research of Medical Science Review. 3, 5 (May 2025), 1163–1167.